Evidence map›Paper›PMID 42694742›Full record

ArticleFrontiers in pharmacology2026

The urgent need to integrate infectious diseases expertise into the management of cancer patients with infections in sub-Saharan Africa in the era of antimicrobial resistance: a policy brief.

Margaret Lubwama, Elizabeth Gulleen, Simon Sekyanzi, Benon Asiimwe, Alhaji Njai, Jody Winter, Lesley Hoyles, Nixon Niyonzima, Jackson Orem, Henry Ddungu and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Margaret LubwamaDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Elizabeth GulleenDivision of Infectious Diseases and Internal Medicine, University of Minnesota, Minneapolis, MN, United States.
Simon SekyanziUganda Cancer Institute, Kampala, Uganda.
Benon AsiimweDepartment of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Alhaji NjaiDepartment of Biological Sciences, Fourah Bay College and Department Microbiology, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Jody WinterDepartment of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom.
Lesley HoylesDepartment of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom.
Nixon NiyonzimaUganda Cancer Institute, Kampala, Uganda.
Jackson OremUganda Cancer Institute, Kampala, Uganda.
Henry DdunguUganda Cancer Institute, Kampala, Uganda.
Joyce KambuguUganda Cancer Institute, Kampala, Uganda.
Annet NakagandaUganda Cancer Institute, Kampala, Uganda.
David P KateeteDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Warren PhippsVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Freddie BwangaDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global health concern. Cancer patients are 1.5-2 times more likely to be affected by AMR than other patient groups. This policy brief, informed by microbiological studies conducted at the Uganda Cancer Institute since 2014, presents key recommendations and implementation strategies for the management of bacterial infections in cancer patients in sub-Saharan Africa (SSA). Our recommendations include strengthening AMR surveillance, implementing context-specific infection prevention and control and antimicrobial stewardship programs, and raising awareness of AMR in cancer in the health sector and community in SSA. A collaborative multidisciplinary approach which includes infectious diseases expertise is required to effectively implement health policies and guidelines. Proactive and effective health policies which address AMR in cancer are critical in cancer centers in SSA.

Indexed as

antimicrobial resistancecancermultidrug-resistantnational cancer control plansub-Saharan AfricaUganda

Identifiers

PMID42694742
PMCPMC13539598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.